Skip to main content
See every side of every news story
Published loading...Updated

Campaigners in final push for Skyclarys approval

Campaigners say the drug could cost about €280,000 per patient a year as the HSE weighs reimbursement at a final meeting.

Summary by RTÉ
A demonstration is being held in Dublin city centre calling on the HSE to approve reimbursement for Skyclarys, a drug used to treat Friedreich's Ataxia.

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources lean Left
80% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Breaking News broke the news in Ireland on Sunday, August 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal